Multisystemic therapy improved adherence to blood glucose testing in adolescents with type 1 diabetesUse of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial.

  • Paterson, Barbara L RN, PhD (commentator)
  • Ellis, DA
  • Frey, MA
  • Naar-King, S
  • et al,

  • University of New Brunswick Fredericton, New Brunswick, Canada

Ellis DA, Frey MA, Naar-King S, et al. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care 2005; 28: 1604–10.EllisDAFreyMANaar-KingSet alUse of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial.Diabetes Care2005281604-10Q Does multisystemic therapy increase adherence to blood glucose testing and insulin use, improve metabolic control, and reduce hospital use in adolescents with type 1 diabetes and chronically poor metabolic control?

For correspondence: Dr D A Ellis, Department of Child Psychiatry and Psychology, Children’s Hospital of Michigan, Detroit, MI, USA. [email protected]

Source of funding: National Institute of Diabetes and Digestive and Kidney Diseases.

Evidence-Based Nursing 9(1):p 14, January 2006.
Copyright © 2006 by BMJ Publishing Group Ltd & Royal College of Nursing